Janux Therapeutics, Inc. (JANX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch JANX
See up to 3 months of JANX. The 7-day demo opens the 1M and 3M ranges and puts JANX on your watchlist.
Start 7-day demoLatest JANX insider trades
About Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. files with the SEC under CIK 0001817713 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
JANX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Bona-fide gift | 1 | 123,840 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
JANX insider transactions (Form 4)
9227 Form 4 filings on record, the earliest from Oct 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Alan Campbell - Officer | Gift | Common Stock | 123,840 | $0.00 | - | |
| David Alan Campbell - Officer | Option exercise | Common Stock | 7,000 | $4.21 | $29K | |
| David Alan Campbell - Officer | Option exercise | Stock Option (right to buy) | 7,000 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Stock Option (Right to Buy) | 15,500 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| ||||||
 Jake Simson | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| Jake Simson | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| ||||||
| Winston Kung | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| Winston Kung | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| ||||||
| Natasha Hernday | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| Natasha Hernday | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| ||||||
| Eric Dobmeier | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| Eric Dobmeier | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| ||||||
| Vickie L. Capps | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| Vickie L. Capps | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| ||||||
| Ronald W. Barrett | Grant or award | Common Stock | 5,500 footnote F1 | $0.00 | - | |
| Ronald W. Barrett | Grant or award | Stock Option (right to buy) | 15,500 | $0.00 | - | |
| ||||||
| Janeen Noel Doyle - Officer | Open-market sale | Common Stock | 4,059 | $14.03 footnote F2 | $57K | |
| ||||||
| Maria Dobek - Officer | Open-market sale | Common Stock | 2,038 | $14.17 | $29K | |
| William Go - Officer | Grant or award | Common Stock | 44,000 footnote F1 | $0.00 | - | |
| William Go - Officer | Grant or award | Stock option (right to buy) | 154,000 | $0.00 | - | |
| ||||||
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 3,333 | $10.59 | $35K | |
| Andrew Hollman Meyer - Officer | Open-market sale | Common Stock | 2,700 | $32.85 footnote F2 | $89K | |
| Andrew Hollman Meyer - Officer | Open-market sale | Common Stock | 633 | $33.52 footnote F3 | $21K | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 3,333 | $0.00 | - | |
| ||||||
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 3,333 | $10.59 | $35K | |
| Andrew Hollman Meyer - Officer | Open-market sale | Common Stock | 3,333 | $30.00 | $100K | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 3,333 | $0.00 | - | |
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 9,999 | $4.21 | $42K | |
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 6,666 | $10.59 | $71K | |
| Andrew Hollman Meyer - Officer | Open-market sale | Common Stock | 16,665 | $30.06 footnote F2 | $501K | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 9,999 | $0.00 | - | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 6,666 | $0.00 | - | |
| ||||||
| Vickie L. Capps | Grant or award | Common Stock | 3,750 | $0.00 | - | |
| Vickie L. Capps | Grant or award | Stock Option (right to buy) | 11,667 | $0.00 | - | |
| Eric Dobmeier | Grant or award | Common Stock | 3,750 | $0.00 | - | |
| Eric Dobmeier | Grant or award | Stock Option (right to buy) | 11,667 | $0.00 | - | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 25,000 | $56.19 | $1.40M | |
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 9,880 | $20.24 | $200K | |
| Andrew Hollman Meyer - Officer | Option exercise | Common Stock | 1 | $14.02 | $14 | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 9,880 | $0.00 | - | |
| Andrew Hollman Meyer - Officer | Option exercise | Stock Option (right to buy) | 1 | $0.00 | - | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 15,000 | $67.00 | $1.00M | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 18,281 | $51.43 | $940K | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 6,719 | $52.04 | $350K | |
| Sheila Gujrathi | Other | Common Stock | 4,611 | $0.00 | - | |
| Vickie L. Capps | Other | Common Stock | 2,305 | $0.00 | - | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 13,897 | $53.22 | $740K | |
| David Alan Campbell - Officer | Open-market sale | Common Stock | 11,103 | $53.94 | $599K | |
| Jay Lichter | Option exercise | Common Stock | 1,868 | $17.00 | $32K | |
| Jay Lichter | Option exercise | Common Stock | 778 | $10.73 | $8K | |
| Jay Lichter | Option exercise | Common Stock | 778 | $13.22 | $10K | |
| Jay Lichter | Option exercise | Common Stock | 391 | $39.80 | $16K | |
| Jay Lichter | Open-market sale | Common Stock | 3,815 | $46.68 | $178K | |
| Jay Lichter | Option exercise | Stock Option (right to buy) | 1,868 | $0.00 | - | |
| Jay Lichter | Option exercise | Stock Option (right to buy) | 778 | $0.00 | - | |
| Jay Lichter | Option exercise | Stock Option (right to buy) | 778 | $0.00 | - | |
| Jay Lichter | Option exercise | Stock Option (right to buy) | 391 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Common Stock | 1,200,000 | $44.75 | $53.70M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 60,179 | $49.69 | $2.99M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 11,657 | $49.69 | $579K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 61,445 | $49.69 | $3.05M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 29,474 | $50.61 | $1.49M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 5,710 | $50.61 | $289K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 30,094 | $50.61 | $1.52M | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 4,968 | $17.00 | $84K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 2,070 | $10.73 | $22K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 2,070 | $13.22 | $27K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 1,407 | $39.80 | $56K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 10,957 | $50.80 | $557K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 836 | $17.00 | $14K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 348 | $10.73 | $4K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 348 | $13.22 | $5K | |
| Avalon Ventures XI, L.P. | Option exercise | Common Stock | 237 | $39.80 | $9K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 1,843 | $50.02 | $92K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 102,732 | $50.30 | $5.17M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 19,900 | $50.30 | $1.00M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 104,892 | $50.30 | $5.28M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 15,462 | $51.18 | $791K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 2,995 | $51.18 | $153K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 15,788 | $51.18 | $808K | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 541,824 | $44.75 | $24.25M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 104,957 | $44.75 | $4.70M | |
| Avalon Ventures XI, L.P. | Open-market sale | Common Stock | 553,219 | $44.75 | $24.76M | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 4,968 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 2,070 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 2,070 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 836 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 348 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 348 | $0.00 | - | |
| Avalon Ventures XI, L.P. | Option exercise | Stock Option (right to buy) | 237 | $0.00 | - | |
Item 2.02, 9.01
Item 8.01
Item 5.07
Item 2.02, 9.01
Recent JANX Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
JANX insider trading FAQ
What is the latest insider trade for JANX?
Janux Therapeutics, Inc. (JANX) had 1 insider filing in the last 90 days, with the most recent on 2026-08-01. The full record for JANX runs to 27 Form 4 filings, the earliest from 2024-10-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying JANX stock?
No insider purchases of JANX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling JANX stock?
No insider sales of JANX were filed in the last 90 days. 30 sales are on record for this company.
Where can I see JANX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects JANX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Alan Campbell view on EDGAR
- - David Alan Campbell view on EDGAR
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Jake Simson view on EDGAR
- - Winston Kung view on EDGAR
- - Natasha Hernday view on EDGAR
- - Eric Dobmeier view on EDGAR
- - Vickie L. Capps view on EDGAR
- - Ronald W. Barrett view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where JANX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow JANX with a 7-day demo
- JANX on your watchlist
- Every JANX Form 4 filing on record
- Up to 3 months of JANX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
